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Abstract−The aim of the present study was to analyze resting-state brain activity in patients 
with Parkinson’s disease (PD), a degenerative disorder of the nervous system. 
Magnetoencephalography (MEG) signals were recorded with a 151-channel whole-head radial 
gradiometer MEG system in 18 early-stage untreated PD patients and 20 age-matched control 
subjects. Artefact-free epochs of four seconds (1250 samples) were analyzed with Lempel-Ziv 
complexity (LZC), applying two and three symbol sequence conversion methods. The results 
showed that MEG signals from PD patients are less complex than control subjects’ recordings. 
We found significant group differences (p-values < 0.01) for the ten major cortical areas 
analyzed (bilateral frontal, central, temporal, parietal and occipital regions). Additionally, using 
receiver operating characteristic (ROC) curves with a leave-one-out cross-validation procedure 
a classification accuracy of 81.58% was obtained. In order to investigate the best combination of 
LZC results for classification purposes, a forward stepwise linear discriminant analysis with 
leave-one out cross-validation was employed. LZC results (three-symbol sequence conversion) 
from right parietal and temporal brain regions were automatically selected by the model. With 
this procedure, an accuracy of 84.21% (77.78% sensitivity, 90.0% specificity) was achieved. 
Our findings demonstrate the usefulness of LZC to detect an abnormal type of dynamics 
associated with PD.  
 
Keywords−Parkinson’s disease, Lempel-Ziv complexity, magnetoencephalography (MEG), 
ROC curves, linear discriminant analysis. 
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1. INTRODUCTION 
Parkinson’s disease (PD) is a progressive neurological disorder that can cause significant 
disability and a reduction in the quality of life. Neuropathologic features are the presence of 
Lewy bodies in the residual dopaminergic neurons and a reduction of dopaminergic neurons in 
the substantia nigra.26 PD affects approximately 1% of the population over 60 years, becoming 
an important medical and social problem.26 The four cardinal symptoms are resting tremor, 
bradykinesia, rigidity and loss of postural reflexes.17 A high number of patients also suffer from 
autonomic, cognitive and psychiatric disturbances.24 The gold-standard criterion for diagnosis is 
the pathological confirmation of the Lewy body on autopsy, but the clinical diagnosis is usually 
based on the patient history and physical examination. The presence of a combination of 
cardinal motor features and response to dopaminergic therapy are characteristic signs of PD.17 
Despite careful examination, the accuracy of clinical diagnosis is only around 80 to 90%.15,16 
Hence, new approaches are needed to improve PD detection. 
Nowadays, magnetoencephalography (MEG) and electroencephalography (EEG) recordings 
are not routinely used as clinical diagnostic procedures in PD. Nevertheless, some studies have 
demonstrated that the analyses of brain signals could help physicians in the diagnosis of this 
disorder.32 Both EEG and MEG are non-invasive techniques that record the electromagnetic 
fields produced by brain activity with good temporal resolution. EEG and MEG signals are 
generated by synchronous oscillations of pyramidal neurons. However, they reflect slightly 
different characteristics, since EEG is sensitive to all primary currents and MEG is only affected 
by current flows oriented parallel to the scalp.13 Additionally, MEG technology offers some 
advantages over EEG. For instance, magnetic fields are not distorted by the resistive properties 
of the skull.13 Furthermore, EEG signals are strongly influenced by a wide variety of factors, 
such as distance between sensors, electrode location, reference point or conducting substance 
between skin and electrode. On the other hand, MEG signals are very sensitive to external 
artefacts. Superconducting quantum interference devices (SQUIDs) and a magnetically shielded 
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room are necessary to detect the weak magnetic signals generated by the brain. 
Several works have focused on spectral analysis of spontaneous EEG/MEG activity in PD 
patients. The most common alteration in PD is generalized slowing of brain activity.3,20,29,33,35  
PD patients showed a power decrease at the EEG beta band and an increase at the theta band.33 
In other work,29 the patients presented diffuse slowing of their quantitative EEG (qEEG) when 
compared with age-matched controls. Finally, also MEG studies showed that PD is associated 
with a slowing of resting state oscillatory brain activity.3,20,35 Stoffers et al not only confirmed 
previously reported slowing, but for the first time made clear that these changes already occur in 
the first clinical stages of PD in untreated patients.35 As an alternative to spectral analyses, some 
research works have focussed on the application of linear connectivity measures to explore the 
functional interactions between brain regions. Silberstein et al observed that EEG coherence in 
the beta band was correlated with the severity of parkinsonism (in the OFF state) in advanced 
stage PD patients considered for deep brain stimulation.30 
Non-linear measures have also offered valuable information to study the changes that PD 
produces into the patients’ brains.32 Using correlation dimension (D2), Stam et al suggested that 
PD is characterized by a complexity decrease in comparison with control subjects.33,34 
Additionally, demented patients had lower largest Lyapunov exponent than PD group.34 On the 
other hand, PD patients showed higher dimensionality than controls during performance of 
complex motor tasks, indicating more complex EEG time series.25 Finally, Anninos et al studied 
the MEG activity in PD, concluding that external magnetic stimulation might help in the 
management of idiopathic PD.2 In sum, D2 is the non-linear measure most widely used to 
characterize EEG/MEG recordings in PD, in spite of its drawbacks from a signal processing 
point of view. First, D2 requires the signals to be stationary and noise free, something that 
cannot be achieved for physiological data. Moreover, long time series are necessary to obtain 
meaningful results.6  Therefore, there is a need for other non-linear methods to enable a proper 
analysis of the electromagnetic brain activity in PD. For instance, synchronization likelihood, a 
nonlinear measure of functional connectivity, revealed significant differences in the MEG 
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background activity between demented and non-demented PD patients.4 Using the same 
measure, Stoffers et al concluded that increased resting-state cortico-cortical functional 
connectivity in the 8–10 Hz alpha range is a feature of PD from the earliest clinical stages.36 
Finally, Pezard et al described higher localized entropy in the EEG of L-Dopa naive PD 
patients.27 
The present study is a new approach to explore the potential of nonlinear methods to 
characterize MEG rhythms in PD. Particularly, the so-called Lempel-Ziv complexity (LZC) was 
used.22 LZC is a complexity measure for finite sequences related to the number of distinct 
substrings and the rate of their occurrence along the sequence.22 LZC has been previously 
applied to MEG recordings to evaluate the complexity alterations produced by different 
pathological states such as mild cognitive impairment,9 Alzheimer’s disease,10,11,14 major 
depressive disorder23 and attention-deficit/hyperactivity disorder.8 To our knowledge, this is the 
first time that this method is applied to study the brain activity in PD. The goal of the present 
study was to analyze the MEG background activity in PD patients to detect the presence of 
abnormal brain dynamics associated with this disorder. Based on the above-mentioned EEG 
studies,33,34 we hypothesized there would be a pattern of reduced LZC values in PD patients, in 
comparison with control subjects. 
2. MATERIALS AND METHODS 
2.1. MEG recording 
The signals were acquired with a 151-channel whole-head radial gradiometer MEG system 
(CTF Systems Inc., Port Coquitlam, BC, Canada) placed in a magnetically shielded room. The 
subjects were seated in a chair, in a relaxed state and with their eyes closed. They were asked to 
stay awake and to avoid making movements. For each subject, MEG registration was performed 
with a 312.5 Hz sampling frequency, using a hardware band-pass filter of 0.25-125 Hz. For each 
subject, twelve artefact-free epochs of 4 seconds (1250 data points) were selected by an 
experienced technician who was blind to the patients’ diagnosis. Subsequently, these epochs 
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were filtered using a FIR (Finite Impulse Response) band-pass filter with a Hamming window 
and cut-off frequencies at 0.5 and 45 Hz. 
2.2. Subjects 
For the present study, we analyzed MEG signals obtained in 18 recently diagnosed PD 
patients (12 men and 6 women) with a mean age of 59.67 ± 7.99 years (mean ± standard 
deviation), never treated with anti-Parkinson medication and with a subjective disease duration 
of less than two years. They were recruited from the outpatient clinic for movement disorders at 
the VU University Medical Center (Amsterdam, the Netherlands). The control group consisted 
of 20 age-matched control subjects without past or present neurological disorders (11 men and 9 
women; mean age = 59.40 ± 7.46). This group was composed of spouses of the patients as well 
as other healthy volunteers. The difference in the mean age of both populations was not 
statistically significant (p-value = 0.91). Cognitive status was screened in both groups using six 
tasks from the Cambridge Neurophychological Test Automated Battery (CANTAB Eclipse 2.0, 
Cambridge Cognition, Cambridge, UK) and two tasks from the Vienna Test System version 6.0 
(Dr. G. Shuhfried GmbH, Mödling, Austria). Prior to the MEG recording, all subjects gave 
written informed consent for the participation in this research work. The medical ethical 
committee of the VU University Medical Center approved the study protocol. 
2.3. Lempel-Ziv complexity (LZC) 
LZC is a measure for sequences of finite length suggested by Lempel and Ziv in 1976.22 
Later, Kaspar and Schuster presented a computer program that determined the LZC using only 
two simple operations: to copy and to insert.19 This program is an appropriate measure of 
complexity in Kolmogorov sense as well as in a statistical sense.39 LZC assigns higher values to 
more complex data. Previous studies have shown that this measure mainly depends on the 
bandwidth of the signal spectrum, although a slight dependence on the sequence probability 
density function was also found.1,7 Additionally, LZC could be interpreted as a harmonic 
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variability metric.1 This measure has already been applied in many different areas, including the 
analysis of biomedical signals, such as EEG recordings,38 MEG signals11 or DNA sequences.12 
LZC analysis is based on a coarse-graining of the measurements, so the MEG time series 
must be transformed into a finite symbol sequence before estimating its complexity. In this 
study, we have used two different sequence conversion methods: 
• 0-1 sequence conversion. The median value is estimated as a threshold Td, as partitioning 
about this value is robust to outliers.28 By comparison with the threshold, the original time 
series X = x(1), x(2),…, x(N) is converted into a 0-1 sequence P = s(1), s(2),…, s(N), 
where s(i) = 0 if x(i) < Td and s(i) = 1 if x(i) ≥ Td.38 
• 0-1-2 sequence conversion. For each of the MEG epochs, the median xm, maximum xmax 
and minimum xmin are calculated. Two thresholds are obtained: Td1 = xm − |xmin|/16 and 
Td2 = xm + |xmax|/16. Then the original time series X is converted into a 0-1-2 sequence P = 
s(1), s(2),…, s(N), where s(i) = 0 if x(i) ≤ Td1, s(i) = 1 if Td1 < x(i) < Td2 and s(i) = 2 if x(i) 
≥ Td2.38 
Afterwards, the new string P is scanned from left to right and a complexity counter c(N) is 
increased by one unit every time a new subsequence of consecutive characters is encountered in 
the scanning process. The detailed algorithm for the measure of the LZC is the following:38 
• Let S and Q denote two subsequences of the original sequence P and SQ be the 
concatenation of S and Q, while SQpi is a string derived from SQ after its last character is 
deleted (pi means the operation to delete the last character). 
• Let v(SQpi) denote the vocabulary of all different substrings of SQpi. 
• At the beginning, the complexity counter c(N) = 1, S = s(1), Q = s(2), SQ = s(1), s(2) and 
SQpi = s(1). 
• In general, suppose that S = s(1), s(2),…, s(r), Q = s(r+1) and, therefore, SQpi = s(1), 
s(2),…, s(r). If Q ∈ v(SQpi), then Q is a subsequence of SQpi, not a new sequence. 
• S does not change and renew Q to be s(r+1), s(r+2), then judge if Q belongs to v(SQpi) or 
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not. 
• The previous two steps are repeated until Q does not belong to v(SQpi). Now Q = s(r+1), 
s(r+2),…, s(r+i) is not a subsequence of SQpi = s(1), s(2),…, s(r+i-1), so increase the 
counter by one. 
• Thereafter, S and Q are combined and renewed to be s(1), s(2),…, s(r+i), and s(r+i+1), 
respectively. 
• Repeat the previous steps until Q is the last character. At this time, the number of 
different substrings is c(N), the measure of complexity. 
In order to obtain a complexity measure which is independent of the sequence length, c(N) 
should be normalized. For a binary conversion, the upper limit of c(N) is given by b(N) = 
N/log2(N), and c(N) can be normalized via b(N): C(N) = c(N)/b(N).22 The normalized LZC, 
C(N), reflects the arising rate of new patterns along with the sequence.38 To ensure that defect-
related features will be included for the complexity calculation, a minimum data length needs to 
be considered.37 Therefore, the effect of the data length on LZC was analyzed for the MEG 
epochs. These analyses showed that the complexity values decline quickly at the beginning and 
become stable from 1000 data points. For this reason, C(n) can be viewed as independent of 
number of samples for epoch lengths higher than 1000 data points. As an example, Fig. 1 
illustrates one curve of the complexity values versus the data length for a MEG recording. Thus, 
an epoch length of 1250 (4 s of recording) was used in our study for the complexity measure. 
DISPLAY FIGURE 1 AROUND HERE 
 
2.4. Statistical analysis 
Initially, a descriptive analysis was performed to explore the distribution for the LZC values. 
Mann-Whitney U-tests were used to evaluate the differences between PD patients and controls. 
In order to address the problem of multiple comparisons, a Bonferroni correction was applied to 
p-values. Bonferroni adjusted p-values are just the normal p-values multiplied by the number of 
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outcomes being tested. 
In addition to these statistical analyses, notched boxplots were used to visualize the 
distributions of the LZC values averaged over the major cortical areas (frontal, central, temporal, 
parietal and occipital) on the left and right sides of the brain. A boxplot is a graphical 
representation that provides a visual summary of several characteristics of a data distribution. 
Moreover, receiver operating characteristic (ROC) curves were used to assess the ability of LZC 
to discriminate PD patients from control subjects in the ten aforementioned brain regions. A 
ROC curve summarizes the performance of a two-class classifier across the range of possible 
thresholds. It is a graphical representation of the trade-offs between sensitivity and specificity. 
Sensitivity is the true positive rate whereas specificity is equal to the true negative rate. 
Accuracy is the percentage of subjects (PD patients and controls) correctly recognized. A leave-
one-out cross-validation procedure was used to calculate sensitivity, specificity and accuracy 
values. In the leave-one-out method, the data from one subject are excluded from the training 
set one at a time and then classified on the basis of the threshold calculated with the data from 
the remaining subjects. The leave-one-out cross-validation procedure provides a nearly unbiased 
estimate of the true error rate of the classification procedure.31 
Finally, a forward stepwise linear discriminant analysis (LDA) with a leave-one-out cross-
validation scheme was performed in order to investigate group classification combining LZC 
results across the ten brain regions. This forward stepwise LDA starts with a model that does 
not include any variable. Then, a forward selection procedure is applied to automatically select 
the first independent variable that will be introduced into the model. This variable is 
characterized by being able to separate the categories as much as possible. Then, the stepwise 
LDA chooses the variable that provides a greater discriminatory ability than others when used 
in conjunction with the previous one. This procedure is repeated until either the measure is 
(locally) maximized or the improvement due to the addition of other independent variable falls 
below some critical value. Results were showed in terms of sensitivity (i.e., proportion of PD 
patients correctly classified), specificity (i.e., percentage of healthy subjects properly identified), 
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and accuracy (i.e., total fraction of subjects well classified). This statistical analysis was 
performed using SPSS software (version 15.0; SPSS Inc, Chicago, IL). 
3. RESULTS 
3.1. Channel-by-channel analysis 
In a first stage, complexity analyses were carried out separately for each MEG channel. We 
have used LZC algorithm to quantify the complexity in MEG time-series of 1250 samples. 
Lempel-Ziv algorithm was applied to each epoch. Then, the twelve epochs corresponding to 
each channel were averaged, obtained a complexity value per channel and subject. Figures 2 and 
3 summarize the average LZC values estimated for PD patients and control subjects at all MEG 
channels for 0–1 and 0–1–2 sequence conversions, respectively. PD patients displayed lower 
LZC values than control subjects for all MEG channels both with the binary as well as the three-
symbol sequence conversion. With the binary conversion, mean values obtained were 0.4809 ± 
0.0269 for controls and 0.4326 ± 0.0299 (mean ± SD) for PD patients. Using three-symbol 
sequence conversion, we obtained mean values of 0.4572 ± 0.0228 for the control group and 
0.4162 ± 0.0245 for the PD group. These results suggest that the complexity, in the sense of 
number of new subsequences in the data, is lower in PD patients’ MEGs than in control 
subjects. Moreover, differences were statistically significant for several channels placed at 
parietal, occipital and temporal regions (Bonferroni adjusted p-values < 0.05). 
DISPLAY FIGURES 2 AND 3 AROUND HERE 
 
3.2. Regional analysis 
In a second stage, we grouped the MEG channels into ten cortical regions (frontal, central, 
temporal, parietal and occipital areas at the right and left sides of the brain) to explore the 
differences between PD patients and controls. Graphical summaries of the distributions are 
depicted in figures 4 and 5, which show the corresponding boxplots at each brain region for 
sequence conversions of two and three symbols. From visual inspection of the plot, it becomes 
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evident that differences in regional LZC values between PD patients and controls subjects were 
statistically significant, as boxplot notches do not overlap. Numerical testing confirmed PD 
patients having lower LZC values than controls for all brain areas examined for both sequence 
conversions. Bonferroni adjusted p-values are displayed in corresponding figures.  
DISPLAY FIGURES 4 AND 5 AROUND HERE 
 
ROC curves with a leave-one-out cross-validation procedure were used to evaluate the 
ability of LZC to distinguish PD patients from control subjects in the aforementioned brain 
regions. The area under the ROC curve (AUC) indicates the probability that a randomly selected 
PD patient has a LZC value lower than a randomly chosen control subject. Sensitivity, 
specificity, accuracy and AUC values obtained with both sequence conversions at each region 
are displayed in tables 1 and 2. 
INSERT TABLES 1 AND 2 AROUND HERE 
 
3.3. Stepwise LDA 
A forward stepwise LDA with a leave-one-out cross-validation procedure was used to 
investigate the best combination of LZC results to classify PD patients and healthy controls. The 
first variable to enter the model was LZC with three-symbol conversion at the right parietal 
brain region. In the next step, LZC with 0–1–2 sequence conversion at the right temporal area 
was added to the model used by the stepwise LDA to classify the subjects. The remaining LZC 
results were left out of the model, since they were linearly related to the variables that had 
already been included into the model and provided no additional information. This LDA model 
achieved an accuracy of 84.21% (77.78% sensitivity, 90.0% specificity). 
4. DISCUSSION AND CONCLUSIONS 
In this study, we analyzed the MEG resting-state activity of 18 early-stage, drug-naive PD 
patients and 20 controls by means of LZC. It was revealed that early-stage PD patients have 
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lower complexity values than controls for all MEG channels. Moreover, significant statistical 
group differences were found for the ten major cortical areas (p-values < 0.05, Mann-Whitney 
U-test with Bonferroni correction). Our findings support the notion that brains affected by PD 
show less complex activity.  
Previous studies have documented that PD involves an overall loss of complexity in the 
electromagnetic background activity.33,34 In the first study mentioned, D2 values in PD patients’ 
EEGs were lower than in controls, but higher than in demented patients.33 The second one 
explored nonlinearity of EEG signals from the same three subjects groups.34 Demented patients 
had significantly lower D2 and lower largest Lyapunov exponent compared to controls, whereas 
largest Lyapunov was higher in PD patients than in demented ones.34 These studies are in 
agreement with our results, supporting the notion that PD is characterized by a EEG/MEG 
complexity decrease.  
More recent studies have applied other measures to study PD-related changes in the MEG 
background activity. Stoffers et al showed extensive changes in oscillatory brain activity in PD 
patients relative to controls, that included widespread increases in theta and alpha power as well 
as overall decreases in beta and gamma power.35 In a subsequent study assessing functional 
connectivity, a global increase in alpha1 synchronization was found in untreated PD patients 
compared to control subjects.36 In line with our current study, both studies demonstrate that PD-
related changes are quite diffuse rather than limited to specific brain regions.35,36 
The methodology applied in this study is a novel approach to analyze the changes in brain 
activity caused by PD. LZC offers some distinct advantages over classical complexity measures. 
First of all, LZC is an easy and fast method to estimate the time series complexity, as only two 
simple mathematical operations are needed for its calculation: sequence comparison and number 
accumulation. Moreover, the median value used as threshold is robust to outliers.28 
Additionally, it can be applied to any time series, irrespective of whether their origin is 
stochastic or deterministic.38 Therefore, only those differences between activity patterns that are 
found to discriminate between PD and control conditions are considered. Nevertheless, the 
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limitations of this measure should also be taken into consideration. Most importantly, LZC is 
based on a coarse-grained measure of the recordings.38 The MEG data were transformed into a 
pattern of a few symbols, only two (0-1) and three (0-1-2) in our study. Thus, it is possible that 
some information from the signal that might have been lost with these symbol conversions 
could have been retained using more symbols.  
ROC curves were used to assess the potential of using LZC values at different brain regions 
to classify PD patients and age-matched control subjects. Our study shows that LZC may be a 
suitable method to differentiate the MEG activity from PD patients and control subjects. The 
highest accuracy (81.57%) was obtained at the right temporal area using LZC with a sequence 
conversion of three symbols. Additionally, we wanted to assess whether LZC values from 
different brain areas could provide complementary information. We applied a forward stepwise 
LDA with a leave-one-out cross-validation procedure, which automatically selected LZC results 
(0–1–2 conversion) from right parietal and temporal areas. With this LDA model, an accuracy 
of 84.21% (77.78% sensitivity, 90.0% specificity) was reached. The accuracy increase is quite 
low (only 2.64%) compared to values obtained with ROC curves at individual brain regions. 
This is due to the fact that LZC results from different brain areas are highly correlated. For this 
reason, LDA modeling does not provide a significant advantage over ROC curves. Although it 
would be great to compare these values with others obtained in previous studies, this research 
work is, to our knowledge, the first that uses brain signals for classification purposes between 
controls and PD patients. Nevertheless, the obtained accuracy suggests that nonlinear analyses 
of the brain activity might be a useful tool to aid physicians in the diagnosis of PD. On the other 
hand, the decreased complexity is not specific of PD and it also appears in other 
neurodegenerative diseases such as vascular dementia,18 mild cognitive impairment9 and 
Alzheimer’s disease.10,11,14 Thus, the present findings should be regarded as preliminary and 
require replication in a larger patient population, including patients with other diagnoses, before 
any conclusion can be made about the clinical diagnostic value of this measure. 
Some potential confounding factors have to be considered. First, a loss of physiological 
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complexity often accompanies ageing.21 However, in the present study the groups were matched 
for age, so the significantly reduced complexity is likely to be a disease-related phenomenon. 
Secondly, the current study was carried out during a resting-state eyes-closed condition. In a 
previous work,5 Cassidy et al suggested that a visuomotor tracking task might increase the 
discrimination between controls and PD patients. Another study revealed that a central 
reduction of EEG complexity during motor tasks, which is normally present in healthy 
individuals, is absent in PD.25 In any case, our results suggest that MEG resting-state 
background activity could be useful to differentiate PD patients from elderly controls. 
In summary, our work presents the LZC as a novel method to study MEG background 
activity in PD patients. It was displayed that PD patients show widespread decreases in LZC 
compared to control subjects. Moreover, an accuracy of 84.21% was achieved in the 
classification between the two groups using a LDA model with a leave-one-out cross-validation 
procedure. Our findings show the usefulness of LZC to detect changes in the dynamical 
behaviour of brains injured by PD. The complexity changes in PD could be related to the 
presence of early, subtle cognitive deficits. 
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FIGURE LEGENDS 
Figure 1. Effect of the epoch length on the C(n) value. 
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Figure 2. Sensor layouts showing the distribution of the LZC values (0–1 sequence conversion) 
at both groups and the corresponding Bonferroni adjusted p-values. 
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Figure 3. Sensor layouts showing the distribution of the LZC values (0–1–2 sequence 
conversion) at both groups and the corresponding Bonferroni adjusted p-values. 
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Figure 4. Notched boxplots displaying the distribution of LZC values (0–1 sequence conversion) 
for each brain area. 
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Figure 5. Notched boxplots displaying the distribution of LZC values (0–1–2 sequence 
conversion) for each brain area. 
 
 
 24
TABLE CAPTIONS 
Table 1. Sensitivity, specificity, accuracy and AUC values obtained with LZC (0–1 sequence 
conversion) for each region. 
Table 2. Sensitivity, specificity, accuracy and AUC values obtained with LZC (0–1–2 sequence 
conversion) for each region. 
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TABLE 1 
 
 
Cortical area 
 
 
Sensitivity 
 
Specificity 
 
Accuracy 
 
AUC 
 
Left central 
 
 
83.33% 
 
75.00% 
 
78.95% 
 
0.8444 
Left frontal 
 
72.22% 55.00% 63.16% 0.8306 
Left occipital 
 
61.11% 65.00% 63.16% 0.7972 
Left parietal 
 
77.78% 75.00% 76.32% 0.8778 
Left temporal 
 
77.78% 80.00% 78.95% 0.8694 
Right central 
 
77.78% 75.00% 76.32% 0.8417 
Right frontal 
 
72.22% 70.00% 71.05% 0.7833 
Right occipital 
 
77.78% 65.00% 71.05% 0.7861 
Right parietal 
 
66.67% 80.00% 73.68% 0.8861 
Right temporal 
 
72.22% 80.00% 76.32% 0.8500 
 
 
TABLE 2 
 
 
Cortical area 
 
 
Sensitivity 
 
Specificity 
 
Accuracy 
 
AUC 
 
Left central 
 
 
77.78% 
 
75.00% 
 
76.32% 
 
0.8361 
Left frontal 
 
72.22% 60.00% 65.79% 0.8279 
Left occipital 
 
61.11% 65.00% 63.16% 0.7972 
Left parietal 
 
77.78% 70.00% 73.68% 0.8778 
Left temporal 
 
77.78% 70.00% 73.68% 0.8778 
Right central 
 
72.22% 75.00% 73.68% 0.8528 
Right frontal 
 
66.67% 65.00% 65.79% 0.7861 
Right occipital 
 
72.22% 70.00% 71.05% 0.8111 
Right parietal 
 
77.78% 80.00% 78.95% 0.8833 
Right temporal 
 
77.78% 85.00% 81.58% 0.8444 
 
